Persantine (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Persantine drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | dipyridamole |
SUBSTANCE NAME: | DIPYRIDAMOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1999-06-01 |
END MARKETING DATE: | 0000-00-00 |
Persantine HUMAN PRESCRIPTION DRUG Details:
Item Description | Persantine from Boehringer Ingelheim Pharmaceuticals, Inc. |
LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 1999-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0597-0017_64df3878-9783-4fe3-86c0-ae13b29af8ab |
PRODUCT NDC: | 0597-0017 |
APPLICATION NUMBER: | NDA012836 |
Other DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers: